Research Summary
I am the founder and chair of the HPV Working Group of the NCI AIDS Malignancy Consortium and the head of the AMC HPV Virology Core Lab. I have extensive experience in studying the molecular biology of HPV infection in HIV-positive men and women and in the design and implementation of clinical research trials of HPV-related disease in this population. I am the protocol chair of the ANCHOR study, an eight-year, 15-site NCI/NIH-funded randomized controlled trial designed to determine whether treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in HIV-infected men and women.
As the founder and director of the Anal Neoplasia Clinic, Research and Education Center at UCSF, I oversee training of clinicians from around the world in high-resolution anoscopy, anal biopsy, and office-based treatment. I have an active international research program, including currently active studies in India, Costa Rica and Thailand. I have published over 275 papers and am the PI on several laboratory-based and clinical research studies of HPV-associated neoplasia, particularly in the setting of HIV infection.
I am currently the president of the International Papillomavirus Society and the founder and immediate past president of the International Anal Neoplasia Society. I have been the leader of the UCSF Doris Duke Charitable Foundation Clinical Research Fellowship Program for medical students since 2001; since 2006, I have led a T32 program devoted to training pre-doctoral students in clinical and translational research. These year-out programs provide support for an intensive year of coursework and project-oriented research with the goal of stimulating pre-doctoral students to pursue further training and careers in clinical and translational research.
Research Funding
August 1, 2019 - July 31, 2024 - California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations , Principal Investigator . Sponsor: NIH, Sponsor Award ID: U54CA242646
August 1, 2016 - July 31, 2022 - (PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA206477
June 1, 2017 - May 31, 2020 - New therapeutic HPV vaccines for HIV infected men and women , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA217715
January 13, 2017 - December 31, 2019 - The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R03CA203589
Education
McGill University, Montreal, Canada, M.D.,C.M., 1980, Medicine
Royal Victoria Hospital, Montreal, Canada, F.R.C.P(C), 1984, Internal Medicine
Stanford University, Stanford, CA, D.A.B.I.M. (Infec Dis), 1989, Medical Microbiology/Infectious Disease